Neurotrophins and their role in the cochlea

Hearing Research

Volumn 288, Issue 1-2, 2012, Pages 19-33

  Ramekers, Dyan ^a   Versnel, Huib ^a   Grolman, Wilko ^a   Klis, Sjaak F L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; NERVE GROWTH FACTOR; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN RECEPTOR; PROTEIN TYROSINE KINASE A;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; AUTOCRINE EFFECT; CELL FUNCTION; CELL LOSS; CELL STRUCTURE; CELL SURVIVAL; CELL THERAPY; CELL TRANSFORMATION; COCHLEA INJURY; COCHLEA INNERVATION; COCHLEA PROSTHESIS; DEGENERATIVE DISEASE; FEASIBILITY STUDY; HAIR CELL; HEARING IMPAIRMENT; HUMAN; INNER EAR DISEASE; INNERVATION; NERVE CELL DEGENERATION; NERVE CELL MEMBRANE; NERVE GROWTH; NONHUMAN; OTOTOXICITY; PEPSIN SECRETION; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; REGULATORY MECHANISM; REINNERVATION; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL; TREATMENT DURATION; TREATMENT RESPONSE;

ANIMALS; AUDITORY PATHWAYS; COCHLEA; HEARING LOSS; HUMANS; NERVE GROWTH FACTORS; NEUROPROTECTIVE AGENTS; RECEPTORS, NERVE GROWTH FACTOR; SIGNAL TRANSDUCTION; SPIRAL GANGLION;

EID: 84861875641     PISSN: 03785955     EISSN: 18785891     Source Type: Journal    
DOI: 10.1016/j.heares.2012.03.002     Document Type: Review

References (154)

1. Acheson A., Conover J.C., Fandl J.P., DeChiara T.M., Russell M., Thadani A., Squinto S.P., Yancopoulos G.D., Lindsay R.M. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 1995, 374:450-453.
2. Adamson C.L., Reid M.A., Davis R.L. Opposite actions of brain-derived neurotrophic factor and neurotrophin-3 on firing features and ion channel composition of murine spiral ganglion neurons. J. Neurosci. 2002, 22:1385-1396.
3. Agerman K., Hjerling-Leffler J., Blanchard M.P., Scarfone E., Canlon B., Nosrat C., Ernfors P. BDNF gene replacement reveals multiple mechanisms for establishing neurotrophin specificity during sensory nervous system development. Development 2003, 130:1479-1491.
4. Agterberg M.J.H., Versnel H., De Groot J.C.M.J., Smoorenburg G.F., Albers F.W.J., Klis S.F.L. Morphological changes in spiral ganglion cells after intracochlear application of brain-derived neurotrophic factor in deafened guinea pigs. Hear. Res. 2008, 244:25-34.
5. Agterberg M.J.H., Versnel H., Van Dijk L.M., De Groot J.C.M.J., Klis S.F.L. Enhanced survival of spiral ganglion cells after cessation of treatment with brain-derived neurotrophic factor in deafened guinea pigs. J. Assoc. Res. Otolaryngol. 2009, 10:355-367.
6. Agterberg M.J.H., Versnel H., de Groot J.C.M.J., van den Broek M., Klis S.F.L. Chronic electrical stimulation does not prevent spiral ganglion cell degeneration in deafened guinea pigs. Hear. Res. 2010, 269:169-179.
7. Aid T., Kazantseva A., Piirsoo M., Palm K., Timmusk T. Mouse and rat BDNF gene structure and expression revisited. J. Neurosci. Res. 2007, 85:525-535.
8. Allen S.J., Dawbarn D. Clinical relevance of the neurotrophins and their receptors. Clin. Sci. 2006, 110:175-191.
9. Altar C.A., Boylan C.B., Jackson C., Hershenson S., Miller J., Wiegand S.J., Lindsay R.M., Hyman C. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc. Natl. Acad. Sci. USA 1992, 89:11347-11351.
10. Altschuler R.A., Cho Y., Ylikoski J., Pirvola U., Magal E., Miller J.M. Rescue and regrowth of sensory nerves following deafferentation by neurotrophic factors. Ann. NY Acad. Sci. 1999, 884:305-311.
11. Ard M.D., Morest D.K., Hauger S.H. Trophic interactions between the cochleovestibular ganglion of the chick embryo and its synaptic targets in culture. Neurosci. 1985, 16:1151-1170.
12. Arévalo J.C., Wu S.H. Neurotrophin signaling: many exciting surprises!. Cell. Mol. Life Sci. 2006, 63:1523-1537.
13. Baj G., Tongiorgi E. BDNF splice variants from the second promoter cluster support cell survival of differentiated neuroblastoma upon cytotoxic stress. J. Cell. Sci. 2009, 122:36-43.
14. Barbacid M. The Trk family of neurotrophin receptors. J. Neurobiol. 1994, 25:1386-1403.
15. Bianchi L.M., Conover J.C., Fritzsch B., DeChiara T., Lindsay R.M., Yancopoulos G.D. Degeneration of vestibular neurons in late embryogenesis of both heterozygous and homozygous BDNF null mutant mice. Development 1996, 122:1965-1973.
16. Bothwel M. Functional interactions of neurotrophins and neurotrophin receptors. Ann. Rev. Neurosci. 1995, 18:223-253.
17. Bowe S.N., Jacob A. Round window perfusion dynamics: implications for intracochlear therapy. Curr. Opin. Otolaryngol. Head Neck Surg. 2010, 18:377-385.
18. Bramham C.R., Messaoudi E. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog. Neurobiol. 2005, 76:99-125.
19. Capsoni S., Ugolini G., Comparini A., Ruberti F., Berardi N., Cattaneo A. Alzheimer-like neurodegeneration in aged anti-nerve growth factor transgenic mice. Proc. Natl. Acad. Sci. USA 2000, 97:6826-6831.
20. Chao M.V. Trophic factors: an evolutionary cul-de-sac or door into higher neuronal function?. J. Neurosci. Res. 2000, 59:353-355.
21. Chen L.W., Yung K.K.L., Chan Y.S., Shum D.K.Y., Bolam J.P. The proNGF-p75NTR-sortilin signalling complex as New target for the therapeutic treatment of Parkinson's disease. CNS Neurol. Disord. Drug Targets 2008, 7:512-523.
22. Cheng P.L., Song A.H., Wong Y.H., Wang S., Zhang X., Poo M.M. Self-amplifying autocrine actions of BDNF in axon development. Proc. Natl. Acad. Sci. USA 2011, 108:18430-18435.
23. Chikar J.A., Colesa D.J., Swiderski D.L., Di Polo A., Raphael Y., Pfingst B.E. Over-expression of BDNF by adenovirus with concurrent electrical stimulation improves cochlear implant thresholds and survival of auditory neurons. Hear. Res. 2008, 245:24-34.
24. Coppola V., Kucera J., Palko M.E., Martinez-De Velasco J., Lyons W.E., Fritzsch B., Tessarollo L. Dissection of NT3 functions in vivo by gene replacement strategy. Development 2001, 128:4315-4327.
25. Dai C.F., Steyger P.S., Wang Z.M., Vass Z., Nuttall A.L. Expression of Trk A receptors in the mammalian inner ear. Hear. Res. 2004, 187:1-11.
26. Davies A.M., Wright E.M. Neurotrophic Factors: neurotrophin autocrine loops. Curr. Biol. 1995, 5:723-726.
27. Davis R.L. Gradients of neurotrophins, ion channels, and tuning in the cochlea. Neuroscientist 2003, 9:311-316.
28. Dawbarn D., Allen S.J. Neurotrophins and neurodegeneration. Neuropathol. Appl. Neurobiol. 2003, 29:211-230.
29. NTR. Curr. Opin. Neurobiol. 1997, 7:413-418.
30. Dodson H.C. Loss and survival of spiral ganglion neurons in the guinea pig after intracochlear perfusion with aminoglycosides. J. Neurocytol. 1997, 26:541-556.
31. Duan M., Agerman K., Ernfors P., Canlon B. Complementary roles of neurotrophin 3 and a N-methyl-D-aspartate antagonist in the protection of noise and aminoglycoside-induced ototoxicity. Proc. Natl. Acad. Sci. USA 2000, 97:7597-7602.
32. Edwards R.H., Selby M.J., Garcia P.D., Rutter W.J. Processing of the native nerve growth factor precursor to form biologically active nerve growth factor. J. Biol. Chem. 1988, 263:6810-6815.
33. Ejstrup R., Kiilgaard J.F., Tucker B.A., Klassen H.J., Young M.J., La Cour M. Pharmacokinetics of intravitreal glial cell line-derived neurotrophic factor: experimental studies in pigs. Exp. Eye Res. 2010, 91:890-895.
34. Endo T., Nakagawa T., Kita T., Iguchi F., Kim T.S., Tamura T., Iwai K., Tabata Y., Ito J. Novel strategy for treatment of inner ears using a biodegradable gel. Laryngoscope 2005, 115:2016-2020.
35. Eriksdotter Jonhagen M.E., Nordberg A., Amberla K., Backman L., Ebendal T., Meyerson B., Olson L., Shigeta M., Theodorsson E., Viitamen M., Winblab B., Wahlund L.O. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 1998, 9:246-257.
36. Ernfors P., Merlio J.P., Persson H. Cells expressing mRNA for neurotrophins and their receptors during embryonic rat development. Eur. J. Neurosci. 1992, 4:1140-1158.
37. Ernfors P., Duan M.L., ElShamy W.M., Canlon B. Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3. Nat. Med. 1996, 2:463-467.
38. Fagan A.M., Zhang H., Landis S., Smeyne R.J., Silos-Santiago I., Barbacid M. TrkA, but not TrkC, receptors are essential for survival of sympathetic neurons in vivo. J. Neurosci. 1996, 16:6208-6218.
39. Fariñas I., Jones K.R., Tessarollo L., Vigers A.J., Huang E., Kirstein M., de Caprona D.C., Coppola V., Backus C., Reichardt L.F., Fritzsch B. Spatial shaping of cochlear innervation by temporally regulated neurotrophin expression. J. Neurosci. 2001, 21:6170-6180.
40. Fayad J.N., Linthicum F.H. Multichannel cochlear implants: relation of histopathology to performance. Laryngoscope 2006, 116:1310-1320.
41. Frade J.M., Rodríguez-Tébar A., Barde Y. Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 1996, 383:166-168.
42. Fransson A., Maruyama J., Miller J.M., Ulfendahl M. Post-treatment effects of local GDNF administration to the inner ears of deafened guinea pigs. J. Neurotrauma 2010, 27:1745-1751.
43. Fritzsch B., Silos-Santiago I., Smeyne R., Fagan A.M., Barbacid M. Reduction and loss of inner ear innervation in TrkB and TrkC receptor knockout mice: a whole mount DiI and scanning electron microscopic analysis. Aud. Neurosci. 1995, 1:401-417.
44. Fritzsch B., Silos-Santiago I., Bianchi L.M., Fariñas I. The role of neurotrophic factors in regulating the development of inner ear innervation. Trends Neurosci. 1997, 20:159-164.
45. Fritzsch B., Fariñas I., Reichardt L.F. Lack of neurotrophin 3 causes losses of both classes of spiral ganglion neurons in the cochlea in a region-specific fashion. J. Neurosci. 1997, 17:6213-6225.
46. Fritzsch B., Pirvola U., Ylikoski J. Making and breaking the innervation of the ear: neurotrophic support during ear development and its clinical implications. Cell Tissue Res. 1999, 295:369-382.
47. Fritzsch B., Tessarollo L., Coppola E., Reichardt L.F. Neurotrophins in the ear: their roles in sensory neuron survival and fiber guidance. Prog. Brain Res. 2004, 146:265-278.
48. Gage F.H., Armstrong D.M., Williams L.R., Varon S. Morphological response of axotomized septal neurons to nerve growth factor. J. Comp. Neurol. 1988, 269:147-155.
49. Gillespie L.N., Clark G.M., Bartlett P.F., Marzella P.L. BDNF-induced survival of auditory neurons in vivo: cessation of treatment leads to accelerated loss of survival effects. J. Neurosci. Res. 2003, 71:785-790.
50. Gillespie L.N., Clark G.M., Marzella P.L. Delayed neurotrophin treatment supports auditory neuron survival in deaf guinea pigs. Neuroreport 2004, 15:1121-1125.
51. Glueckert R., Bitsche M., Miller J.M., Zhu Y., Prieskorn D.M., Altschuler R.A., Schrott-Fischer A. Deafferentation-associated changes in afferent and efferent processes in the guinea pig cochlea and afferent regeneration with chronic intrascalar brain-derived neurotrophic factor and acidic fibroblast growth factor. J. Comp. Neurol. 2008, 507:1602-1621.
52. Green S.H., Altschuler R.A., Miller J.M. Cell death and cochlear protection. Auditory Trauma, Protection, and Repair 2008, 275-319. Springer, New York. J. Schacht, A.N. Popper, R.R. Fay (Eds.).
53. Greenberg M.E., Xu B., Lu B., Hempstead B.L. New insights in the biology of BDNF synthesis and release: implications in CNS function. J. Neurosci. 2009, 29:12764-12767.
54. Haque N.S.K., Hlavin M., Fawcett J.W., Dunnett S.B. The neurotrophin NT4/5, but not NT3, enhances the efficacy of nigral grafts in a rat model of Parkinson's disease. Brain Res. 1996, 712:45-52.
55. Havenith S., Versnel H., Agterberg M.J.H., De Groot J.C.M.J., Sedee R., Grolman W., Klis S.F.L. Spiral ganglion cell survival after round window membrane application of brain-derived neurotrophic factor using gelfoam as carrier. Hear. Res. 2011, 272:168-177.
56. Hayashi T., Ray C.A., Younkins C., Bermingham-McDonogh O. Expression patterns of FGF receptors in the developing mammalian cochlea. Dev. Dyn. 2010, 239:1019-1026.
57. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J. Neurosci. 1986, 6:2155-2162.
58. Hennigan A., O'Callaghan R.M., Kelly á.M. Neurotrophins and their receptors: roles in plasticity, neurodegeneration and neuroprotection. Biochem. Soc. Trans. 2007, 35:424-426.
59. Hoglinger G.U., Sautter J., Meyer M., Spenger C., Seiler R.W., Oertel W.H., Widmer H.R. Rat ventral mesencephalon grown as solid tissue cultures: influence of culture time and BDNF treatment on dopamine neuron survival and function. Brain Res. 1998, 813:313-322.
60. Hong E.J., McCord A.E., Greenberg M.E. A biological function for the neuronal activity-dependent component of Bdnf transcription in the development of cortical inhibition. Neuron 2008, 60:610-624.
61. Hossain W.A., Morest D.K. Fibroblast growth factors (FGF-1, FGF-2) promote migration and neurite growth of mouse cochlear ganglion cells in vitro: immunohistochemistry and antibody perturbation. J. Neurosci. Res. 2000, 62:40-55.
62. Huang E.J., Reichardt L.F. Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 2001, 24:677-736.
63. Huang E.J., Reichardt L.F. Trk receptors: roles in neuronal signal transduction. Ann. Rev. Biochem. 2003, 72:609-642.
64. Ivanicevic L., Saragovi H.U. The neurotrophins. Handbook of Biologically Active Peptides 2006, 1409-1411. Academic Press, Burlington. A.J. Kastin (Ed.).
65. Johnson E.M., Yip H.K. Central nervous system and peripheral nerve growth factor provide trophic support critical to mature sensory neuronal survival. Nature 1985, 314:751-752.
66. Kanzaki S., Stöver T., Kawamoto K., Prieskorn D.M., Altschuler R.A., Miller J.M., Raphael Y. Glial cell line-derived neurotrophic factor and chronic electrical stimulation prevent VIII cranial nerve degeneration following denervation. J. Comp. Neurol. 2002, 454:350-360.
67. Khan A.M., Handzel O., Burgess B.J., Damian D., Eddington D.K., Nadol J.B. Is word recognition correlated with the number of surviving spiral ganglion cells and electrode insertion depth in human subjects with cochlear implants?. Laryngoscope 2005, 115:672-677.
68. Kim J.R., Abbas P.J., Brown C.J., Etler C.P., O'Brien S., Kim L.S. The relationship between electrically evoked compound action potential and speech perception: a study in cochlear implant users with short electrode array. Otol. Neurotol. 2010, 31:1041-1048.
69. Kishino A., Katayama N., Ishige Y., Yamamoto Y., Ogo H., Tatsuno T., Mine T., Noguchi H., Nakayama C. Analysis of effects and pharmacokinetics of subcutaneously administered BDNF. Neuroreport 2001, 12:1067-1072.
70. Koliatsos V.E., Nauta H.J., Clatterbuck R.E., Holtzman D.M., Mobley W.C., Price D.L. Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkey. J. Neurosci. 1990, 10:3801-3813.
71. Kuang R., Hever G., Zajic G., Yan Q., Collins F., Louis J.C., Keithley E., Magal E. Glial cell line-derived neurotrophic factor. Potential for otoprotection. Ann. N. Y. Acad. Sci. 1999, 884:270-291.
72. Kujawa S.G., Liberman M.C. Acceleration of age-related hearing loss by early noise exposure: evidence of a misspent youth. J. Neurosci. 2006, 26:2115-2123.
73. Kujawa S.G., Liberman M.C. Adding insult to injury: cochlear nerve degeneration after " temporary" noise-induced hearing loss. J. Neurosci. 2009, 29:14077-14085.
74. Kuribara M., Hess M.W., Cazorla M., Roubos E.W., Scheenen W.J., Jenks B.G. Brain-derived neurotrophic factor stimulates growth of pituitary melanotrope cells in an autocrine way. Gen. Comp. Endocrinol. 2011, 170:156-161.
75. Kuribara M., Kidane A.H., Vos G.A., de Gouw D., Roubos E.W., Scheenen W.J., Jenks B.G. Extracellular-signal regulated kinase regulates production of pro-opiomelanocortin in pituitary melanotroph cells. J. Neuroendocrinol. 2011, 23:261-268.
76. Küst B.M., Copray J.C., Brouwer N., Troost D., Boddeke H.W. Elevated levels of neurotrophins in human biceps brachii tissue of amyotrophic lateral sclerosis. Exp. Neurol. 2002, 177:419-427.
77. Landry T.G., Wise A.K., Fallon J.B., Shepherd R.K. Spiral ganglion neuron survival and function in the deafened cochlea following chronic neurotrophic treatment. Hear. Res. 2011, 282:303-313.
78. Leake P.A., Hradek G.T. Cochlear pathology of long term neomycin induced deafness in cats. Hear. Res. 1988, 33:11-33.
79. Leake P.A., Hradek G.T., Hetherington A.M., Stakhovskaya O. Brain-derived neurotrophic factor promotes cochlear spiral ganglion cell survival and function in deafened, developing cats. J. Comp. Neurol. 2011, 519:1526-1545.
80. Leake P.A., Rebscher S.J. Anatomical considerations and long-term effects of electrical stimulation. Cochlear Implants: Auditory Prostheses and Electric Hearing 2004, 101-148. New York. F.G. Zeng, A.N. Popper, R.R. Fay (Eds.).
81. Leingärtner A., Lindholm D. Two promoters direct transcription of the mouse NT-3 gene. Eur. J. Neurosci. 1994, 6:1149-1159.
82. Lee R., Kermani P., Teng K.K., Hempstead B.L. Regulation of cell survival by secreted proneurotrophins. Science 2001, 294:1945-1948.
83. Lee Y.-W., Ozeki M., Juhn S.K., Lin J. Expression of platelet-derived growth factor in the developing cochlea of rats. Acta Otolaryngol. 2004, 124:558-562.
84. Lefebvre P.P., Van de Water T.R., Weber T., Rogister B., Moonen G. Growth factor interactions in cultures of dissociated adult acoustic ganglia: neuronotrophic effects. Brain Res. 1991, 567:306-312.
85. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., Collins F. A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurones. Science 1993, 260:1130-1132.
86. Linthicum F.H., Fayad J., Otto S.R., Galey F.R., House W.F. Cochlear implant histopathology. Am. J. Otol. 1991, 12:245-311.
87. Liu Y., Okada T., Shimazaki K., Sheykholeslami K., Nomoto T., Muramatsu S., Mizukami H., Kume A., Xiao S., Ichimura K., Ozawa K. Protection against aminoglycoside-induced ototoxicity by regulated AAV vector-mediated GDNF gene transfer into the cochlea. Mol. Ther. 2008, 16:474-480.
88. Lucidi-Phillipi C.A., Gage F.H., Shults C.W., Jones K.R., Reichardt L.F., Kang U.J. Brain-derived neurotrophic factor-transduced fibroblasts: production of BDNF and effects of grafting to the adult rat brain. J. Comp. Neurol. 1995, 354:361-376.
89. Malgrange B., Rogister B., Lefebvre P.P., Mazy-Servais C., Welcher A.A., Bonnet C., Hsu R.-Y., Rigo J.-M., Van de Water T.R., Moonen G. Expression of growth factors and their receptors in the postnatal rat cochlea. Neurochem. Res. 1998, 23:1133-1138.
90. Maruyama J., Miller J.M., Ulfendahl M. Glial cell line-derived neurotrophic factor and antioxidants preserve the electrical responsiveness of the spiral ganglion neurons after experimentally induced deafness. Neurobiol. Dis. 2008, 29:14-21.
91. McFadden S.L., Ding D., Jiang H., Salvi R.J. Time course of efferent fiber and spiral ganglion cell degeneration following complete hair cell loss in the chinchilla. Brain Res. 2004, 997:40-51.
92. McGuinness S.L., Shepherd R.K. Exogenous BDNF rescues rat spiral ganglion neurons in vivo. Otol. Neurotol. 2005, 26:1064-1072.
93. Merrill D.R., Bikson M., Jefferys J.G. Electrical stimulation of excitable tissue: design of efficacious and safe protocols. J. Neurosci. Methods 2005, 141:171-198.
94. Miller J.M., Altschuler R.A. Effectiveness of different electrical stimulation conditions in preservation of spiral ganglion cells following deafness. Ann. Otol. Rhinol. Laryngol. Suppl. 1995, 166:57-60.
95. Miller J.M., Chi D.H., O'Keeffe L.J., Kruszka P., Raphael Y., Altschuler R.A. Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss. Int. J. Dev. Neurosci. 1997, 15:631-643.
96. Miller J.M., Le Prell C.G., Prieskorn D.M., Wys N.L., Altschuler R.A. Delayed neurotrophin treatment following deafness rescues spiral ganglion cells from death and promotes regrowth of auditory nerve peripheral processes: effects of brain-derived neurotrophic factor and fibroblast growth factor. J. Neurosci. Res. 2007, 85:1959-1969.
97. Mitchell A., Miller J.M., Finger P.A., Heller J.W., Raphael Y., Altschuler R.A. Effects of chronic high-rate electrical stimulation on the cochlea and eighth nerve in the deafened guinea pig. Hear. Res. 1997, 105:30-43.
98. Montero C.N., Hefti F. Rescue of lesioned septal cholinergic neurons by nerve growth factor: specificity and requirement for chronic treatment. J. Neurosci. 1988, 8:2986-2999.
99. Nam Y.-J., Stöver T., Hartman S.S., Altschuler R.A. Upregulation of glial cell line-derived neurotrophic factor (GDNF) in the rat cochlea following noise. Hear. Res. 2000, 146:1-6.
100. Noushi F., Richardson R.T., Hardman J., Clark G., O'Leary S. Delivery of neurotrophin-3 to the cochlea using alginate beads. Otol. Neurotol. 2005, 26:528-533.
101. Numakawa T., Suzuki S., Kumamaru E., Adachi N., Richards M., Kunugi H. BDNF function and intracellular signaling in neurons. Histol. Histopathol. 2010, 25:237-258.
102. Patapoutian A., Reichardt L.F. Trk receptors: mediators of neurotrophin action. Curr. Opin. Neurobiol. 2001, 11:272-280.
103. Pettingill L.N., Richardson R.T., Wise A.K., Shepherd R.K., O'Leary S. Neurotrophic factors and neural prostheses: potential clinical applications based upon findings in the auditory system. IEEE Trans. Biomed. Eng. 2007, 54:1138-1148.
104. Pettingill L.N., Wise A.K., Geaney M.S., Shepherd R.K. Enhanced auditory neuron survival following cell-based BDNF treatment in the deaf guinea pig. PLoS One 2011, 6:e18733.
105. Pfingst B.E., Bowling S.A., Colesa D.J., Garadat S.N., Raphael Y., Shibata S.B., Strahl S.B., Su G.L., Zhou N. Cochlear infrastructure for electrical hearing. Hear. Res. 2011, 281:65-73.
106. Pfingst B.E., Xu L., Thompson C.S. Effects of carrier pulse rate and stimulation site on modulation detection by subjects with cochlear implants. J. Acoust. Soc. Am. 2007, 121:2236-2246.
107. Pirvola U., Ylikoski J., Palgi J., Lehtonen E., Arumäe U., Saarma M. Brain-derived neurotrophic factor and neurotrophin 3 mRNAs in the peripheral target fields of developing inner ear ganglia. Proc. Natl. Acad. Sci. USA 1992, 89:9915-9919.
108. Prado-Guitierrez P., Fewster L.M., Heasman J.M., McKay C.M., Shepherd R.K. Effect of interphase gap and pulse duration on electrically evoked potentials is correlated with auditory nerve survival. Hear. Res. 2006, 215:47-55.
109. Pruunsild P., Kazantseva A., Aid T., Palm K., Timmusk T. Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics 2007, 90:397-406.
110. Puel J.L., Ruel J., Gervais d'Aldin C., Pujol R. Excitotoxicity and repair of cochlear synapses after noise-trauma induced hearing loss. Neuroreport 1998, 9:2109-2114.
111. Qun L.X., Pirvola U., Saarma M., Ylikoski J. Neurotrophic factors in the auditory periphery. Ann. N.Y. Acad. Sci. 1999, 884:292-304.
112. Rattay F., Lutter P., Felix H. A model of the electrically excited human cochlear neuron. I. Contribution of neural substructures to the generation and propagation of spikes. Hear. Res. 2001, 153:43-63.
113. Rejali D., Lee V.A., Abrashkin K.A., Humayun N., Swiderski D.L., Raphael Y. Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons. Hear. Res. 2007, 228:180-187.
114. Reichardt L.F. Neurotrophin-regulated signalling pathways. Phil. Trans. R. Soc. 2006, 361:1545-1564.
115. Richardson R.T., O'Leary S., Wise A., Hardman J., Clark G. A single dose of neurotrophin-3 to the cochlea surrounds spiral ganglion neurons and provides trophic support. Hear. Res. 2005, 204:37-47.
116. Roehm P.C., Hansen M.R. Strategies to preserve or regenerate spiral ganglion neurons. Curr. Opin. Otolaryngol. Head Neck Surg. 2005, 13:294-300.
117. Schecterson L.C., Bothwell M. Neurotrophin and neurotrophin receptor mRNA expression in developing inner ear. Hear. Res. 1994, 73:92-100.
118. Scheper V., Paasche G., Miller J.M., Warnecke A., Berkingali N., Lenarz T., Stöver T. Effects of delayed treatment with combined GDNF and continuous electrical stimulation on spiral ganglion cell survival in deafened guinea pigs. J. Neurosci. Res. 2009, 87:1389-1399.
119. Schindler R.A., Gladstone H.B., Scott N., Hradek G.T., Williams H., Shah S.B. Enhanced preservation of the auditory nerve following cochlear perfusion with nerve growth factors. Am. J. Otol. 1995, 16:304-309.
120. Schinstine M., Kawaja M.D., Gage F.H. Intracerebral delivery of growth factors: potential application of genetically modified fibroblasts. Prog. Growth Factor Res. 1991, 3:57-66.
121. Sekimoto M., Fukamachi K., Nemoto F., Miyata S., Degawa M., Senba E., Ueyama T., Nemoto K. Novel alternative splicing in the 5' exon of the neurotrophin-3 gene. Neuroreport 1998, 9:3675-3679.
122. Shah S.B., Gladstone H.B., Williams H., Hradek G.T., Schindler R.A. An extended study: protective effects of nerve growth factor in neomycin-induced auditory neural degeneration. Am. J. Otol. 1995, 16:310-314.
123. Shepherd R.K., Coco A., Epp S.B., Crook J.M. Chronic depolarization enhances the trophic effects of brain-derived neurotrophic factor in rescuing auditory neurons following a sensorineural hearing loss. J. Comp. Neurol. 2005, 486:145-158.
124. Shepherd R.K., Coco A., Epp S.B. Neurotrophins and electrical stimulation for protection and repair of spiral ganglion neurons following sensorineural hearing loss. Hear. Res. 2008, 242:100-109.
125. Shibata S.B., Cortez S.R., Beyer L.A., Wiler J.A., Di Polo A., Pfingst B.E., Raphael Y. Transgenic BDNF induces nerve fiber regrowth into the auditory epithelium in deaf cochleae. Exp. Neurol. 2010, 223:464-472.
126. Shibata S.B., Budenz C.L., Bowling S.A., Pfingst B.E., Raphael Y. Nerve maintenance and regeneration in the damaged cochlea. Hear. Res. 2011, 281:56-64.
127. Shinohara T., Bredberg G., Ulfendahl M., Pyykkö I., Olivius N.P., Kaksonen R., Lindström B., Altschuler R., Miller J.M. Neurotrophic factor intervention restores auditory function in deafened animals. Proc. Natl. Acad. Sci. USA 2002, 99:1657-1660.
128. Staecker H., Jolly C., Garnham C. Cochlear implantation: an opportunity for drug development. Drug Discov. Today 2010, 15:314-321.
129. Staecker H., Kopke R., Malgrange B., Lefebvre P., Van de Water T.R. NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells. Neuroreport 1996, 7:889-894.
130. Stenqvist A., Agerman K., Marmigère F., Minichiello L., Ernfors P. Genetic evidence for selective neurotrophin 3 signalling through TrkC but not TrkB in vivo. EMBO Rep. 2005, 6:973-978.
131. Stöver T., Gong T.L., Cho Y., Altschuler R.A., Lomax M.I. Expression of the GDNF family members and their receptors in the mature rat cochlea. Brain Res. Mol. Brain Res. 2000, 76:25-35.
132. Suzuki M., Yagi M., Brown J.N., Miller A.L., Miller J.M., Raphael Y. Effect of transgenic GDNF expression on gentamicin-induced cochlear and vestibular toxicity. Gene Ther. 2000, 7:1046-1054.
133. Tauszig-Delamasure S., Bouzas-Rodriguez J. Targeting neurotrophin-3 and its dependence receptor tyrosine kinase receptor C: a new antitumoral strategy. Expert Opin. Ther. Targets 2011, 15:847-858.
134. Takahashi M. The GDNF/RET signaling pathway and human diseases. Cytokine Growth Factor Rev. 2001, 12:361-373.
135. Teng K.K., Felice S., Kim T., Hempstead B.L. Understanding proneurotrophin actions: recent advances and challenges. Dev. Neurobiol. 2010, 70:350-359.
136. Tessarollo L., Coppola V., Fritzsch B. NT-3 replacement with brain-derived neurotrophic factor redirects vestibular nerve fibers to the cochlea. J. Neurosci. 2004, 24:2575-2584.
137. Thiele C.J., Li Z., McKee A.E. On Trk - the TrkB signal transduction pathway is an increasingly important target in cancer biology. Clin. Cancer Res. 2009, 15:5962-5967.
138. Thoenen H. Neurotrophins and neuronal plasticity. Science 1995, 270:593-598.
139. Tuszynski M.H., U H.S., Amaral D.G., Gage F.H. Nerve growth factor infusion in the Primate brain reduces lesion-induced cholinergic neuronal degeneration. J. Neurosci. 1990, 10:3604-3614.
140. Van Ruijven M.W.M., de Groot J.C.M.J., Smoorenburg G.F. Time sequence of degeneration pattern in the guinea pig cochlea during cisplatin administration. A quantitative histological study. Hear. Res. 2004, 197:44-54.
141. Van Westerlaak M.G.H., Bär P.R., Cools A.R., Joosten E.A.J. Malonate-induced cortico-motoneuron death is attenuated by NT-4, but not by BDNF or NT-3. Neuroreport 2001, 12:1355-1358.
142. Versnel H., Agterberg M.J.H., de Groot J.C.M.J., Smoorenburg G.F., Klis S.F.L. Time course of cochlear electrophysiology and morphology after combined administration of kanamycin and furosemide. Hear. Res. 2007, 231:1-12.
143. Webster M., Webster D.B. Spiral ganglion neuron loss following organ of Corti loss: a quantitative study. Brain Res. 1981, 212:17-30.
144. Wheeler E.F., Bothwell M., Schecterson L.C., Von Bartheld C.S. Expression of BDNF and NT-3 mRNA in hair cells of the organ of Corti: quantitative analysis in developing rats. Hear. Res. 1994, 73:46-56.
145. Wise A.K., Fallon J.B., Neil A.J., Pettingill L.N., Geaney M.S., Skinner S.J., Shepherd R.K. Combining cell-based therapies and neural prostheses to promote neural survival. Neurotherapeutics 2011, 8:774-787.
146. Wise A.K., Richardson R., Hardman J., Clark G., O'leary S. Resprouting and survival of guinea pig cochlear neurons in response to the administration of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3. J. Comp. Neurol. 2005, 487:147-165.
147. Wright T.J., Hatch E.P., Karabagli H., Karabagli P., Schoenwolf G.C., Mansour S.L. Expression of mouse fibroblast growth factor and fibroblast growth factor receptor genes during early inner ear development. Dev. Dyn. 2003, 228:267-272.
148. Xu S.A., Shepherd R.K., Chen Y., Clark G.M. Profound hearing loss in the cat following the single co-administration of kanamycin and ethacrynic acid. Hear. Res. 1993, 70:205-215.
149. Yagi M., Kanzaki S., Kawamoto K., Shin B., Shah P.P., Magal E., Sheng J., Raphael Y. Spiral ganglion neurons are protected from degeneration by GDNF gene therapy. J. Assoc. Res. Otolaryngol. 2000, 1:315-325.
150. Yamagata T., Miller J.M., Ulfendahl M., Olivius N.P., Altschuler R.A., Pyykkö I., Bredberg G. Delayed neurotrophic treatment preserves nerve survival and electrophysiological responsiveness in neomycin-deafened guinea pigs. J. Neurosci. Res. 2004, 78:75-86.
151. Ylikoski J., Pirvola U., Moshnyakov M., Palgi J., Arumäe U., Saarma M. Expression patterns of neurotrophin and their receptor mRNAs in the rat inner ear. Hear. Res. 1993, 65:69-78.
152. Ylikoski J., Pirvola U., Virkkala J., Suvanto P., Liang X.Q., Magal E., Altschuler R., Miller J.M., Saarma M. Guinea pig auditory neurons are protected by glial cell line-derived growth factor from degeneration after noise trauma. Hear. Res. 1998, 124:17-26.
153. Ylikoski J., Wersall J., Bjorkroth B. Degeneration of neural elements in the cochlea of the guinea pig after damage to the organ of corti by ototoxic antibiotics. Acta Otolaryngol. Suppl. 1974, 326:23-41.
154. Zha X.M., Bishop J.F., Hansen M.R., Victoria L., Abbas P.J., Mouradian M.M., Green S.H. BDNF synthesis in spiral ganglion neurons is constitutive and CREB-dependent. Hear. Res. 2001, 156:53-68.